Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay.

Gabrielli BG, Sarcevic B, Sinnamon J, Walker G, Castellano M, Wang XQ, Ellem KA.

J Biol Chem. 1999 May 14;274(20):13961-9.

2.
4.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

5.
6.
7.
8.

Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ.

Cancer Res. 1996 Jul 1;56(13):2973-8.

9.

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.

Fry DW, Bedford DC, Harvey PH, Fritsch A, Keller PR, Wu Z, Dobrusin E, Leopold WR, Fattaey A, Garrett MD.

J Biol Chem. 2001 May 18;276(20):16617-23. Epub 2001 Feb 6.

11.

Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.

Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.

Hepatology. 1999 Feb;29(2):385-95.

PMID:
9918914
12.

Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.

Nishiwaki E, Turner SL, Harju S, Miyazaki S, Kashiwagi M, Koh J, Serizawa H.

Mol Cell Biol. 2000 Oct;20(20):7726-34.

13.

Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.

Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10699-704.

14.

Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.

Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.

Oncogene. 1997 Mar 20;14(11):1329-40.

15.
16.

The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.

Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.

Cancer Res. 1996 Dec 1;56(23):5475-83.

18.

Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.

Cheng L, Rossi F, Fang W, Mori T, Cobrinik D.

J Biol Chem. 2000 Sep 29;275(39):30317-25.

19.
20.

Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.

Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP.

Curr Biol. 1996 Jan 1;6(1):84-91.

Supplemental Content

Support Center